CSPC Pharmaceutical Group Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| 600276 | Jiangsu Hengrui Medicine | Outperform |
15
|
¥45.61 | ¥56.49 | 18.40% | 0 | ¥265.02B |
| BGNE | BeiGene | Buy |
6
|
$153.58 | $285.19 | 79.06% | 2 | $13.53B |
| 600196 | Shanghai Fosun Pharmaceutical ... | Outperform |
16
|
¥23.19 | ¥33.57 | 25.70% | 1 | ¥54.65B |
| 1801 | Innovent Biologics | Buy |
6
|
HK$39.15 | HK$50.72 | 29.76% | 6 | HK$53.87B |
| 600062 | China Resources Double-Crane P... | Buy |
16
|
¥21.20 | ¥26.00 | 21.42% | 0 | ¥21.83B |
| 4105 | TTY Biopharm Company | Hold |
18
|
NT$76.60 | NT$86.00 | 12.92% | 0 | NT$19.67B |
| PSTV | Plus Therapeutics | Outperform |
11
|
$1.69 | $11.00 | 373.37% | 2 | $6.97M |